Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...

Earlier this year, researchers at CHOP and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder. KJ Muldoon ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

Ecuadorian scientists have, for the first time, edited the gene of a fungus that destroys banana plantations. Using an ...

Intellia had already paused dosing in trials of nex-z in transthyretin amyloidosis after the patient was hospitalized due to a serious adverse event.

The clinical hold follows Intellia's disclosure that it paused dosing in two Phase III trials after a patient experienced a serious adverse event.

Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...

Intellia Therapeutics has paused dosing in its Phase 3 MAGNITUDE trials after a patient experienced severe liver toxicity, as the company investigates and works with regulators on its CRISPR-based ...

If you like this video and would like to see more like it, make sure to subscribe to Eurogamer on YouTube. Why did The Callisto Protocol fail? Despite what was promised, the final game was nowhere ...

AUSTIN -- Texas quarterback Arch Manning was in concussion protocol and did not practice Monday ahead of the No. 20 Longhorns' game against No. 9 Vanderbilt. Coach Steve Sarkisian said the team would ...